These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31822720)

  • 1. Metformin activates KDM2A to reduce rRNA transcription and cell proliferation by dual regulation of AMPK activity and intracellular succinate level.
    Tanaka Y; Konishi A; Obinata H; Tsuneoka M
    Sci Rep; 2019 Dec; 9(1):18694. PubMed ID: 31822720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of ROS by Gallic Acid Activates KDM2A to Reduce rRNA Transcription.
    Tanaka Y; Obinata H; Konishi A; Yamagiwa N; Tsuneoka M
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild Glucose Starvation Induces KDM2A-Mediated H3K36me2 Demethylation through AMPK To Reduce rRNA Transcription and Cell Proliferation.
    Tanaka Y; Yano H; Ogasawara S; Yoshioka S; Imamura H; Okamoto K; Tsuneoka M
    Mol Cell Biol; 2015 Dec; 35(24):4170-84. PubMed ID: 26416883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CxxC-ZF domain is needed for KDM2A to demethylate histone in rDNA promoter in response to starvation.
    Tanaka Y; Umata T; Okamoto K; Obuse C; Tsuneoka M
    Cell Struct Funct; 2014; 39(1):79-92. PubMed ID: 24553073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation.
    Tanaka Y; Okamoto K; Teye K; Umata T; Yamagiwa N; Suto Y; Zhang Y; Tsuneoka M
    EMBO J; 2010 May; 29(9):1510-22. PubMed ID: 20379134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallic Acid Derivatives Propyl Gallate and Epigallocatechin Gallate Reduce rRNA Transcription via Induction of KDM2A Activation.
    Tanaka Y; Tsuneoka M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A CxxC domain that binds to unmethylated CpG is required for KDM2A to control rDNA transcription].
    Tsuneoka M; Tanaka Y; Okamoto K
    Yakugaku Zasshi; 2015; 135(1):11-21. PubMed ID: 25743893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1.
    Gao R; Dong R; Du J; Ma P; Wang S; Fan Z
    Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.
    Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG
    J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells.
    Rizwani W; Schaal C; Kunigal S; Coppola D; Chellappan S
    PLoS One; 2014; 9(7):e100888. PubMed ID: 25029110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
    Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
    Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone demethylase KDM2A suppresses EGF-TSPAN8 pathway to inhibit breast cancer cell migration and invasion in vitro.
    Zhang H; Tu Y; Huang B; Xiao J; Xiao J; Wang J; Pei Y; Yang R; Feng J; Li J; Zhang X
    Biochem Biophys Res Commun; 2022 Nov; 628():104-109. PubMed ID: 36084547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation of fumarase maintains tumour growth under glucose deficiency.
    Wang T; Yu Q; Li J; Hu B; Zhao Q; Ma C; Huang W; Zhuo L; Fang H; Liao L; Eugene Chin Y; Jiang Y
    Nat Cell Biol; 2017 Jul; 19(7):833-843. PubMed ID: 28628081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.
    Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG
    J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1.
    Chen JY; Li CF; Chu PY; Lai YS; Chen CH; Jiang SS; Hou MF; Hung WC
    Oncotarget; 2016 May; 7(19):27689-710. PubMed ID: 27029061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling.
    Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T
    PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3.
    Lu B; Wei J; Zhou H; Chen J; Li Y; Ye L; Zhao W; Wu S
    Cell Death Dis; 2022 Jun; 13(6):547. PubMed ID: 35697678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AMP-activated protein kinase in mechanism of metformin action.
    Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
    J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
    Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
    J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.